MedTrace Logo

MitraClip NT System Post-marketing Surveillance Study - Japan

NCT03500692 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2024-07-23

Study results available
· View outcomes & findings →

Summary

The purpose of the MitraClip post-marketing clinical use surveillance study is to observe the frequency, type and degree of adverse device effects and adverse events in order to assure the safety of the new medical device, and to collect safety and efficacy information for evaluating the results of the clinical use.

Conditions

  • Mitral Regurgitation
  • Mitral Valve Regurgitation

Interventions

DEVICE

MitraClip NT System

Percutaneous mitral valve repair using MitraClip NT System

Sponsors & Collaborators

  • Abbott

    collaborator INDUSTRY

  • Abbott Medical Devices

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-02
Primary Completion
2019-03-31
Completion
2022-03-23

Countries

  • Japan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03500692 on ClinicalTrials.gov